[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354393-105":59,"doc-detail-354393-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mir-145-restoration-overcomes-oxaliplatin-resistance-via-abcc1-in-colorectal-cancer","miR-145 restoration overcomes oxaliplatin resistance via ABCC1 in colorectal cancer","","Drug resistance limits chemotherapy effectiveness in colorectal cancer, making strategies that re-sensitize chemo-resistant cells essential. This study restores microRNA-145 expression in oxaliplatin-resistant CRC cells to exploit combined chemotherapy and gene-therapy effects. Bioinformatic screening identified reduced miR-145 in tumors. Functional assays assessed viability, apoptosis, gene and protein expression, and migration after miR-145 restoration, oxaliplatin treatment, or their combination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-145-restoration-overcomes-oxaliplatin-resistance-via-abcc1-in-colorectal-cancer/354393/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-145-restoration-overcomes-oxaliplatin-resistance-via-abcc1-in-colorectal-cancer/354393.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is oxaliplatin resistance a problem in colorectal cancer?","Question",{"text":112,"@type":113},"Drug resistance reduces the effectiveness of chemotherapy in colorectal cancer, leading to therapeutic failure and poor survival in late-stage disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was miR-145 restored in oxaliplatin-resistant SW-480 cells?",{"text":117,"@type":113},"Oxaliplatin-resistant SW-480 cells were generated and transfected with a pCMV-miR-145 expression vector to restore microRNA-145 expression.",{"name":119,"@type":110,"acceptedAnswer":120},"What changes occurred when miR-145 was combined with oxaliplatin?",{"text":121,"@type":113},"Co-treatment significantly lowered cell viability, proliferation, and migration while increasing apoptosis compared with either treatment alone, alongside downregulation of resistance-related genes and oncogenic markers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354393,1790174275,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Sadeghzadeh etal. Journal of the Egyptian National Cancer Institute (2026) 38:17  \n[https://doi.org/10.1186/s43046-026-00349-8](https://doi.org/10.1186/s43046-026-00349-8)  \nJournal of the Egyptian National Cancer Institute  \nRESEARCH Open Access  \nmiR-145 restoration overcomes oxaliplatin resistance via ABCC1 in colorectal cancer  \nMahsa Sadeghzadeh1, Milad Asadi1,2, Behzad Baradaran 1, Venus Zafari2, Soghra Bornehdeli 1, Haniye Mohammad Reza Khani 1, Behzad Mansoori 1, Habib Zarredar3* and Dariush Shanehbandi1*  \nAbstract  \nBackground Drug resistance limits effectiveness of chemotherapy in colorectal cancer (CRC) . Consequently, finding appropriate strategies for re-sensitizing chemo-resistant cells is crucial. Our present study aimed at taking advantage of chemotherapy and gene therapy by restoring microRNA-145 expression in oxaliplatin resistant CRC cells.  \nMethods Bioinformatic analysis of clinical CRC datasets demonstrated significantly reduced miR-145 expression in tumor tissues compared with normal samples. Oxaliplatin-resistant SW-480 cells were generated and transfected with a pCMV-miR-145 expression vector. The MTT assay was used to assess cell viability following miR-145 restoration, oxaliplatin treatment, or their combination. Apoptosis was measured via flow cytometry. Gene expression levels of ABCC1, MDR1, K-RAS, MMP-13, Bcl-2, CASP3, CASP8, and CASP9 were analyzed using qRT-PCR, and ABCC1 protein expression was evaluated by western blotting. Cell migration was assessed using a wound-healing assay.  \nResults Co-treatment with miR-145 and Oxaliplatin significantly reduced cell viability, proliferation, and migration and increased apoptosis compared to the either treatments. Restoring miR-145 expression downregulated reduced the drug-resistance genes ABCC1 and MDR1, and reduced decreased expression of oncogenes including K-RAS and Bcl-2, while increasing expression of apoptosis-related genes (CASP3, CASP8, and CASP9) .  \nConclusion miR-145 restoration via decreasing the drug resistance biomarkers ABBCC1 and MDR1, along with otheroncogenes like K-Ras and Bcl2, and increasing apoptosis conductors could sensitize oxaliplatin-resistant cells to chemotherapy. This proposes a novel and clinically translatable strategy to control drug resistance in CRC, finding new ways to increasing chemotherapeutic efficacy.  \nKeywords Colorectal cancer, SW-480 cells, Oxaliplatin, Drug resistance, microRNA-145, Apoptosis, MDR1, ABCC1  \n*Correspondence:  \nHabib Zarredar [Habib_zarredar@yahoo.com](Habib_zarredar@yahoo.com)[ ](Habib_zarredar@yahoo.com)Dariush Shanehbandi [dariush.shanehbandi@gmail.com](dariush.shanehbandi@gmail.com)  \n1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n2Department of Basic Oncology, Institute of Health Sciences, Ege University, Izmir, Turkey  \n3Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nSadeghzadeh et al. Journal of the Egyptian National Cancer Institute  \nIntroduc","cbCaial1ny6uhU97","https://ap.wps.com/l/cbCaial1ny6uhU97","pdf",5259790,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why is oxaliplatin resistance a problem in colorectal cancer?\",\"answer\":\"Drug resistance reduces the effectiveness of chemotherapy in colorectal cancer, leading to therapeutic failure and poor survival in late-stage disease.\"},{\"question\":\"How was miR-145 restored in oxaliplatin-resistant SW-480 cells?\",\"answer\":\"Oxaliplatin-resistant SW-480 cells were generated and transfected with a pCMV-miR-145 expression vector to restore microRNA-145 expression.\"},{\"question\":\"What changes occurred when miR-145 was combined with oxaliplatin?\",\"answer\":\"Co-treatment significantly lowered cell viability, proliferation, and migration while increasing apoptosis compared with either treatment alone, alongside downregulation of resistance-related genes and oncogenic markers.\"}]","miR-145 restoration overcomes oxaliplatin resistance via ABCC1 in colorectal cancer | PDF",1790110427,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce8c2dbd5e951296bb2015b122e244d1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b62f79ad92fec23761ce73d81093780e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56acf8f92b6e0637e5dde449a7926e55.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d53feabb2cd87d181be1f539a71af99.webp",980,1306]